Development and clinical application of gene therapy of the advanced and recurrent head and neck cancer using transformed lactobacillus
Project/Area Number |
23659791
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Otorhinolaryngology
|
Research Institution | Tohoku University |
Principal Investigator |
ASADA Yukinori 東北大学, 医学(系)研究科(研究院), 非常勤講師 (70436103)
|
Co-Investigator(Kenkyū-buntansha) |
SHIGA Kiyoto 岩手医科大学, 医学部, 教授 (10187338)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2013: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2012: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 組換え体乳酸菌 / 頭頸部癌 / 腫瘍免疫 / 遺伝子治療 / サイトカイン / 頭頸部扁平上皮癌 |
Research Abstract |
Two cell lines originated from head and neck squamous cell carcinoma, HSC2 and SAS were used to make transfered tumors on the back of nude mice. We administered two kinds of transformed lactobacillus casei into which IL2 gene and only vector plasmids were introduced. We used 5-day consecutive administration schedule. IL2-introduce lactobacillus showed significant tumor suppressive effects on SAS and HSC2. On the other hand, vector plasmid-introduce lactobacillus showed suppressive effects on HSC2. One nude mouse showed complete regression of the HSC2 tumor against IL2-introduce lactobacillus. Serum level of TNFa, IL12, and so on were significantly elevated in the lactobacillus administrated mice indicating the Th1 type immune response. Lactobacilli were observed in the tumor tissue of the mice, but was never observed in primary organs such as lung, liver, kidney.
|
Report
(4 results)
Research Products
(7 results)
-
[Journal Article] Matched-pair analysis in patients with advanced oropharyngeal cancer: surgery versus concurrent chemoradiotherapy.2013
Author(s)
Kano S, Homma A, Hayashi R, Kawabata K, Yoshino K, Iwae S, Hasegawa Y, Nibu K, Kato T, Shiga K, Matsuura K, Monden N, Fujii M.
-
Journal Title
Oncology
Volume: 84
Issue: 5
Pages: 290-298
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Malignant melanoma of the head and neck : A multi-institutional retrospective analysis of cases in Northern Japan2012
Author(s)
Shiga K, Ogawa T, Kobayashi T, Ueda S, Kondo A, Nanba A, Kuwashima S, Asada Y, Suzuki S, Nagahashi T, Takahashi M, Suzuki M, Ishida A, Watanabe K, Harabuchi Y, Himi T, Shinkawa H, Sato H, Saijyo S, Fukuda S, Tanaka K, Ishikawa K, Omori K, Aoyagi M, Hashimoto S
-
Journal Title
Head Neck
Volume: (in press)
Issue: 11
Pages: 1537-1541
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] miR-34a is downregulated in cis-diamminedichloroplatinum treated sinonasal squamous cell carcinoma patients with poor prognosis2012
Author(s)
Takenori Ogawa, Yuriko Saiki, Kiyoto Shiga, Na Chen, Shinichi Fukushige, Makoto Sunamura, Hiroki Nagase, Sho Hashimoto, Kazuto Matsuura, Shigeru Saijo, Toshimitsu Kobayashi and Akira Horii
-
Journal Title
Cancer Sci
Volume: 103
Pages: 1737-1743
Related Report
Peer Reviewed
-
-